Common use of Array Responsibilities Clause in Contracts

Array Responsibilities. Array shall with due diligence provide the following services and resources to ICOS and conduct the following activities in accordance with the Optimization Plan: (a) During the Optimization Period, Array shall (i) review data and information regarding Active Targets and lead compounds provided by ICOS; (ii) based on such data and information design Daughter Libraries and optimize the lead compounds supplied by ICOS and (iii) synthesize compounds as provided in Section 6.3 below; (b) During the Optimization Period, Array shall keep ICOS regularly informed of its activities performed in connection with the Optimization Program, including, without limitation, providing ICOS with data and information (and, upon ICOS's written request, reasonable quantities of samples pursuant to Section 6.3) regarding the status of Array's work on Optimization Compounds under the Optimization Plan; [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) Subject to Sections 3.3, 4 and 7, and at all times during the Optimization Period, Array shall [ * ].

Appears in 1 contract

Sources: Drug Discovery Collaboration Agreement (Array Biopharma Inc)

Array Responsibilities. Array shall with due diligence provide the following services and resources to ICOS and conduct the following activities in accordance with the Optimization Plan: (a) During the Optimization Period, Array shall (i) review data and information regarding the Active Targets Target and lead compounds provided by ICOS; (ii) based on such data and information design Daughter Libraries and optimize the lead compounds supplied by ICOS ICOS; and (iii) synthesize compounds as provided in Section 6.3 5.3 below;. (b) During the Optimization Period, Array shall keep ICOS regularly informed of its activities performed in connection with the Optimization Program, including, without limitation, providing ICOS with data and information (and, upon ICOS's written request, reasonable quantities of samples pursuant to Section 6.35.3) regarding the status of Array's work on Optimization Compounds under the Optimization Plan; . (c) Subject to Sections 2.3, 3 and 6, and at all times during the Optimization Period, Array shall [ * ]. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) Subject to Sections 3.3, 4 and 7, and at all times during the Optimization Period, Array shall [ * ].

Appears in 1 contract

Sources: Lead Optimization Agreement (Array Biopharma Inc)